454 related articles for article (PubMed ID: 36076260)
21. YAP/TAZ-mediated regulation of laminin 332 is enabled by β4 integrin repression of ZEB1 to promote ferroptosis resistance.
Goel HL; Karner ER; Kumar A; Mukhopadhyay D; Goel S; Mercurio AM
J Biol Chem; 2024 Apr; 300(4):107202. PubMed ID: 38508310
[TBL] [Abstract][Full Text] [Related]
22. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
[TBL] [Abstract][Full Text] [Related]
23. Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth.
Koo JH; Plouffe SW; Meng Z; Lee DH; Yang D; Lim DS; Wang CY; Guan KL
Genes Dev; 2020 Jan; 34(1-2):72-86. PubMed ID: 31831627
[TBL] [Abstract][Full Text] [Related]
24. Roles of YAP/TAZ in ferroptosis.
Magesh S; Cai D
Trends Cell Biol; 2022 Sep; 32(9):729-732. PubMed ID: 35701310
[TBL] [Abstract][Full Text] [Related]
25. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Nishina H
Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
[TBL] [Abstract][Full Text] [Related]
26. Gingival proteomics reveals the role of TGF beta and YAP/TAZ signaling in Raine syndrome fibrosis.
Costa CRR; Chalgoumi R; Baker A; Guillou C; Yamaguti PM; Simancas Escorcia V; Abbad L; Amorin BR; de Lima CL; Cannaya V; Benassarou M; Berdal A; Chatziantoniou C; Cases O; Cosette P; Kozyraki R; Acevedo AC
Sci Rep; 2024 Apr; 14(1):9497. PubMed ID: 38664418
[TBL] [Abstract][Full Text] [Related]
27. Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases.
Li R; Huang W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675179
[TBL] [Abstract][Full Text] [Related]
28. Mechanosignaling YAP/TAZ-TEAD Axis Regulates the Immunomodulatory Properties of Mesenchymal Stem Cells.
Yoshii H; Kajiya M; Yoshino M; Morimoto S; Horikoshi S; Tari M; Motoike S; Iwata T; Ouhara K; Ando T; Yoshimoto T; Shintani T; Mizuno N
Stem Cell Rev Rep; 2024 Jan; 20(1):347-361. PubMed ID: 37917410
[TBL] [Abstract][Full Text] [Related]
29. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
[TBL] [Abstract][Full Text] [Related]
30. Insights into recent findings and clinical application of YAP and TAZ in cancer.
Franklin JM; Wu Z; Guan KL
Nat Rev Cancer; 2023 Aug; 23(8):512-525. PubMed ID: 37308716
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of YAP/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells.
Fu J; Liu W; Liu S; Zhao R; Hayashi T; Zhao H; Xiang Y; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Cell Signal; 2024 Jul; 119():111186. PubMed ID: 38643945
[TBL] [Abstract][Full Text] [Related]
32. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
Patel SH; Camargo FD; Yimlamai D
Gastroenterology; 2017 Feb; 152(3):533-545. PubMed ID: 28003097
[TBL] [Abstract][Full Text] [Related]
33. Yap and Taz regulate retinal pigment epithelial cell fate.
Miesfeld JB; Gestri G; Clark BS; Flinn MA; Poole RJ; Bader JR; Besharse JC; Wilson SW; Link BA
Development; 2015 Sep; 142(17):3021-32. PubMed ID: 26209646
[TBL] [Abstract][Full Text] [Related]
34. Integrin signalling regulates YAP and TAZ to control skin homeostasis.
Elbediwy A; Vincent-Mistiaen ZI; Spencer-Dene B; Stone RK; Boeing S; Wculek SK; Cordero J; Tan EH; Ridgway R; Brunton VG; Sahai E; Gerhardt H; Behrens A; Malanchi I; Sansom OJ; Thompson BJ
Development; 2016 May; 143(10):1674-87. PubMed ID: 26989177
[TBL] [Abstract][Full Text] [Related]
35. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
[TBL] [Abstract][Full Text] [Related]
36. YAP/TAZ Mediate TGFβ2-Induced Schlemm's Canal Cell Dysfunction.
Li H; Singh A; Perkumas KM; Stamer WD; Ganapathy PS; Herberg S
Invest Ophthalmol Vis Sci; 2022 Nov; 63(12):15. PubMed ID: 36350617
[TBL] [Abstract][Full Text] [Related]
37. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
38. YAP/TAZ at the Roots of Cancer.
Zanconato F; Cordenonsi M; Piccolo S
Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434
[TBL] [Abstract][Full Text] [Related]
39. YAP/TAZ activation mediates PQ-induced lung fibrosis by sustaining senescent pulmonary epithelial cells.
Yu Y; Chu C; Wang K; Li Y; Mao Z; Hu L; Wang J; Yu Y; Sun H; Chen F
Respir Res; 2024 May; 25(1):212. PubMed ID: 38762455
[TBL] [Abstract][Full Text] [Related]
40. Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options.
Strepkos D; Markouli M; Papavassiliou KA; Papavassiliou AG; Piperi C
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12762. PubMed ID: 34409639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]